US Stock MarketDetailed Quotes

RGBP REGEN BIOPHARMA INC

Watchlist
  • 0.379
  • -0.001-0.29%
15min DelayClose Jul 31 16:00 ET
1.56MMarket Cap-1578P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
Total revenue
0.00%59.07K
0.00%59.07K
0.44%236.56K
0.00%59.37K
0.59%59.07K
1.19%59.07K
0.00%59.07K
37.57%235.52K
-0.58%59.37K
3.68%58.72K
Operating revenue
0.00%59.07K
0.00%59.07K
0.44%236.56K
0.00%59.37K
0.59%59.07K
1.19%59.07K
0.00%59.07K
37.57%235.52K
-0.58%59.37K
3.68%58.72K
Cost of revenue
Gross profit
Operating expense
16.12%160.14K
-65.23%181.85K
60.58%923.51K
-24.62%118.45K
22.61%144.22K
2.26%137.91K
216.00%522.93K
54.62%575.12K
-15.76%157.15K
18.67%117.63K
Selling and administrative expenses
18.28%120K
-68.57%134.32K
137.28%711.21K
-10.51%83.12K
14.62%99.22K
43.92%101.46K
758.37%427.42K
-10.60%299.73K
-43.96%92.88K
2.00%86.57K
-General and administrative expense
18.28%120K
-68.57%134.32K
137.28%711.21K
-10.51%83.12K
14.62%99.22K
43.92%101.46K
758.37%427.42K
-10.60%299.73K
-43.96%92.88K
2.00%86.57K
Research and development costs
10.12%40.13K
-50.24%47.53K
-22.91%212.3K
-45.02%35.34K
44.88%45K
-43.38%36.45K
-17.44%95.51K
650.29%275.39K
208.82%64.27K
117.91%31.06K
Operating profit
-28.19%-101.07K
73.53%-122.78K
-102.28%-686.95K
39.57%-59.09K
-44.55%-85.16K
-3.07%-78.84K
-335.87%-463.87K
-69.15%-339.61K
22.90%-97.78K
-38.64%-58.91K
Net non-operating interest income expense
-77.10%-21.4K
-27.49%-22.13K
-21.43%-309.45K
-229.83%-265.94K
73.20%-14.06K
81.24%-12.09K
69.72%-17.36K
30.53%-254.83K
33.80%-80.63K
12.39%-52.47K
Non-operating interest income
----
----
--0
--0
--0
----
----
97.83%455
-58.21%56
38.54%133
Non-operating interest expense
77.10%21.4K
27.49%22.13K
-71.66%59.45K
-54.70%15.94K
-73.27%14.06K
-81.27%12.09K
-69.79%17.36K
-42.84%209.79K
-71.14%35.19K
-12.31%52.6K
Total other finance cost
----
----
449.45%250K
----
----
----
----
--45.5K
----
----
Other net income (expense)
-109.68%-204.85K
-29.13%2.15M
0
100.05%35.95K
-24.63%2.12M
149.02%3.04M
108.84%100.38K
1,007.97%67.07M
Gain on sale of security
----
-109.68%-204.85K
-36.16%2.15M
--0
----
100.05%35.95K
-25.53%2.12M
162.16%3.37M
127.85%100.38K
1,007.97%67.07M
Special income (charges)
----
--0
101.21%1.15K
--0
--0
----
101.21%1.15K
87.75%-95.02K
--0
--0
-Less:Other special charges
----
----
-101.21%-1.15K
--0
----
----
-101.21%-1.15K
-87.75%95.02K
--0
----
Other non- operating income (expenses)
----
----
----
----
----
----
----
---237.3K
--0
----
Income before tax
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
994.07%66.96M
Income tax
Net income
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
994.07%66.96M
Net income continuous Operations
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
994.07%66.96M
Minority interest income
Net income attributable to the parent company
-122.77%-122.47K
-124.15%-349.76K
-54.04%1.02M
-314.66%-280.24K
-100.16%-99.22K
99.92%-54.98K
-39.42%1.45M
132.92%2.23M
95.12%-67.58K
913.61%60.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-122.77%-122.47K
-124.15%-349.76K
-54.04%1.02M
-314.66%-280.24K
-100.16%-99.22K
99.92%-54.98K
-39.42%1.45M
132.92%2.23M
95.12%-67.58K
913.61%60.93M
Basic earnings per share
0.00%-0.03
-122.22%-0.1
-59.17%0.29
-920.41%-0.1
-100.16%-0.03
99.86%-0.03
-70.00%0.45
121.04%0.7102
97.39%-0.0098
706.67%19.11
Diluted earnings per share
0.00%-0.03
-122.22%-0.1
-59.17%0.29
-920.41%-0.1
-100.16%-0.03
99.86%-0.03
-70.00%0.45
121.04%0.7102
97.39%-0.0098
706.67%19.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022
Total revenue 0.00%59.07K0.00%59.07K0.44%236.56K0.00%59.37K0.59%59.07K1.19%59.07K0.00%59.07K37.57%235.52K-0.58%59.37K3.68%58.72K
Operating revenue 0.00%59.07K0.00%59.07K0.44%236.56K0.00%59.37K0.59%59.07K1.19%59.07K0.00%59.07K37.57%235.52K-0.58%59.37K3.68%58.72K
Cost of revenue
Gross profit
Operating expense 16.12%160.14K-65.23%181.85K60.58%923.51K-24.62%118.45K22.61%144.22K2.26%137.91K216.00%522.93K54.62%575.12K-15.76%157.15K18.67%117.63K
Selling and administrative expenses 18.28%120K-68.57%134.32K137.28%711.21K-10.51%83.12K14.62%99.22K43.92%101.46K758.37%427.42K-10.60%299.73K-43.96%92.88K2.00%86.57K
-General and administrative expense 18.28%120K-68.57%134.32K137.28%711.21K-10.51%83.12K14.62%99.22K43.92%101.46K758.37%427.42K-10.60%299.73K-43.96%92.88K2.00%86.57K
Research and development costs 10.12%40.13K-50.24%47.53K-22.91%212.3K-45.02%35.34K44.88%45K-43.38%36.45K-17.44%95.51K650.29%275.39K208.82%64.27K117.91%31.06K
Operating profit -28.19%-101.07K73.53%-122.78K-102.28%-686.95K39.57%-59.09K-44.55%-85.16K-3.07%-78.84K-335.87%-463.87K-69.15%-339.61K22.90%-97.78K-38.64%-58.91K
Net non-operating interest income expense -77.10%-21.4K-27.49%-22.13K-21.43%-309.45K-229.83%-265.94K73.20%-14.06K81.24%-12.09K69.72%-17.36K30.53%-254.83K33.80%-80.63K12.39%-52.47K
Non-operating interest income ----------0--0--0--------97.83%455-58.21%5638.54%133
Non-operating interest expense 77.10%21.4K27.49%22.13K-71.66%59.45K-54.70%15.94K-73.27%14.06K-81.27%12.09K-69.79%17.36K-42.84%209.79K-71.14%35.19K-12.31%52.6K
Total other finance cost --------449.45%250K------------------45.5K--------
Other net income (expense) -109.68%-204.85K-29.13%2.15M0100.05%35.95K-24.63%2.12M149.02%3.04M108.84%100.38K1,007.97%67.07M
Gain on sale of security -----109.68%-204.85K-36.16%2.15M--0----100.05%35.95K-25.53%2.12M162.16%3.37M127.85%100.38K1,007.97%67.07M
Special income (charges) ------0101.21%1.15K--0--0----101.21%1.15K87.75%-95.02K--0--0
-Less:Other special charges ---------101.21%-1.15K--0---------101.21%-1.15K-87.75%95.02K--0----
Other non- operating income (expenses) -------------------------------237.3K--0----
Income before tax -122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K994.07%66.96M
Income tax
Net income -122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K994.07%66.96M
Net income continuous Operations -122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K994.07%66.96M
Minority interest income
Net income attributable to the parent company -122.77%-122.47K-124.15%-349.76K-54.04%1.02M-314.66%-280.24K-100.16%-99.22K99.92%-54.98K-39.42%1.45M132.92%2.23M95.12%-67.58K913.61%60.93M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -122.77%-122.47K-124.15%-349.76K-54.04%1.02M-314.66%-280.24K-100.16%-99.22K99.92%-54.98K-39.42%1.45M132.92%2.23M95.12%-67.58K913.61%60.93M
Basic earnings per share 0.00%-0.03-122.22%-0.1-59.17%0.29-920.41%-0.1-100.16%-0.0399.86%-0.03-70.00%0.45121.04%0.710297.39%-0.0098706.67%19.11
Diluted earnings per share 0.00%-0.03-122.22%-0.1-59.17%0.29-920.41%-0.1-100.16%-0.0399.86%-0.03-70.00%0.45121.04%0.710297.39%-0.0098706.67%19.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.03%